Skip to main content
. 2020 Jun 23;69(12):2523–2532. doi: 10.1007/s00262-020-02641-5

Fig. 3.

Fig. 3

Anlotinib activates intratumoral NK cells. a Representative dot plots showing NK cell (CD3NK1.1+) tumor infiltration (left) and the percentages in TIL (right). b Expression of CD107a and IFN-γ in NK cells. Results are the means ± SEM, n = 5, one-way ANOVA. *p < 0.05, **p < 0.01